Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioTech International was a medical device and biomaterials company specializing in the development and manufacture of advanced polyurethane materials for healthcare applications. The company's flagship technology, ChronoFlex, is a family of biodurable, polycarbonate-based thermoplastic polyurethanes used in long-term implantable devices such as chronic catheters and vascular grafts. Beyond materials, the company developed proprietary medical devices and provided contract manufacturing services. In 2008, the company rebranded as AdvanSource Biomaterials to focus on its core polymer business, and the successor entity was eventually acquired by Mitsubishi Chemical in 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioTech International.